
Global Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028
Description
Global Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028
Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028
The non-hodgkin lymphoma (NHL) therapeutics market is forecasted to grow by USD 6956.5 mn during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the non-hodgkin lymphoma (NHL) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent approvals and strong pipeline, growing geriatric population, and special drug designations.
Technavio's non-hodgkin lymphoma (NHL) therapeutics market is segmented as below:
- By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
- Others
- By Therapy
- Immunotherapy
- Targeted therapy
- Chemotherapy
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the non-hodgkin lymphoma (NHL) therapeutics market covers the following areas:
- Non-hodgkin lymphoma (NHL) therapeutics market sizing
- Non-hodgkin lymphoma (NHL) therapeutics market forecast
- Non-hodgkin lymphoma (NHL) therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
190 Pages
- Market overview
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2023
- Market outlook: Forecast for 2023-2028
- Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market 2018 - 2022
- Distribution Channel segment analysis 2018 - 2022
- Therapy segment analysis 2018 - 2022
- Geography segment analysis 2018 - 2022
- Country segment analysis 2018 - 2022
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Distribution Channel
- Hospital pharmacy - Market size and forecast 2023-2028
- Retail pharmacy - Market size and forecast 2023-2028
- Online pharmacy - Market size and forecast 2023-2028
- Others - Market size and forecast 2023-2028
- Market opportunity by Distribution Channel
- Market segments
- Comparison by Therapy
- Immunotherapy - Market size and forecast 2023-2028
- Targeted therapy - Market size and forecast 2023-2028
- Chemotherapy - Market size and forecast 2023-2028
- Market opportunity by Therapy
- Customer landscape overview
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2023-2028
- Europe - Market size and forecast 2023-2028
- Asia - Market size and forecast 2023-2028
- Rest of World (ROW) - Market size and forecast 2023-2028
- US - Market size and forecast 2023-2028
- UK - Market size and forecast 2023-2028
- Germany - Market size and forecast 2023-2028
- China - Market size and forecast 2023-2028
- Canada - Market size and forecast 2023-2028
- Market opportunity by geography
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market opportunities/restraints
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
- Companies profiled
- Market positioning of companies
- AstraZeneca Plc
- Bayer AG
- BeiGene Ltd.
- Biogen Inc.
- Bristol Myers Squibb Co.
- Eisai Co. Ltd.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Scope of the report
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.